ArticleJournal of thrombosis and haemostasis : JTH2025
Structural and functional changes underlying activation of monocytes in heparin-induced thrombocytopenia.
Article in Journal of thrombosis and haemostasis : JTH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundHeparin-induced thrombocytopenia (HIT) is an antibody-mediated disorder associated with thrombosis developing in response to anticoagulation with heparin. Monocytes targeted by HIT antibodies contribute to the prothrombotic state, but structural and functional alterations of the activated monocytes have not been described.
objectivesTo study morphologic and functional changes in monocytes caused by HIT antibodies interacting with membrane-associated platelet factor 4 (PF4) in vitro.
methodsTHP-1, isolated human, or FcγRIIA-positive and FcγRIIA-negative mouse monocytes were incubated with recombinant human PF4 and/or anti-PF4/heparin antibodies followed by scanning electron microscopy and confocal microscopy.
resultsBinding of PF4 to monocytes induced formation of "knobs" ∼150 nm in size that protruded from the cell surface. Addition of pathogenic HIT-like monoclonal antibodies (KKO) caused profound remodeling of the cell membrane and time-dependent formation and clustering of KKO/PF4/glycosaminoglycan complexes into large "blebs" ranging in size from 500 to 1200 nm. Dynamic confocal microscopy revealed formation of monocyte-derived microvesicles in response to PF4 and KKO. In contrast, RTO, a monoclonal antibody that blocks PF4 oligomerization and prevents thrombocytopenia/thrombosis in an animal HIT model, inhibited PF4-induced modification of monocyte surfaces. Comparing monocytes from transgenic mice expressing hFcγRIIA to wild-type mice lacking FcγRIIA indicated that bleb formation results from clustering of knobs caused by bivalent HIT antibodies through crosslinking of FcγRIIA.
conclusionsBinding of pathogenic HIT antibodies to PF4-containing antigenic complexes assembled on the monocyte surface promotes large-scale plasma membrane remodeling as part of cell activation through the FcγRIIA receptors, resulting in the release of procoagulant microvesicles, which together may contribute to thrombosis in HIT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.